NCT03269630 New Orleans Pulmonary Hypertension Biobank
| NCT ID | NCT03269630 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Louisiana State University Health Sciences Center in New Orleans |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2017-12-29 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2017-12-29 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR * Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR * Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR * Undergoing outpatient right heart catheterization Exclusion Criteria: * Age\<18 * Pregnant * Unable to understand English * Currently incarcerated * Unwilling or unable to sign informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03269630 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03269630 currently recruiting?
Yes, NCT03269630 is actively recruiting participants. Contact the research team at mlammi@lsuhsc.edu for enrollment information.
Where is the NCT03269630 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT03269630 clinical trial?
NCT03269630 is sponsored by Louisiana State University Health Sciences Center in New Orleans. The trial plans to enroll 450 participants.